Product NDC: | 61314-019 |
Proprietary Name: | DORZOLAMIDE HYDROCHLORIDE |
Non Proprietary Name: | dorzolamide hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; dorzolamide hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61314-019 |
Labeler Name: | Sandoz Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078981 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090601 |
Package NDC: | 61314-019-05 |
Package Description: | 5 mL in 1 BOTTLE (61314-019-05) |
NDC Code | 61314-019-05 |
Proprietary Name | DORZOLAMIDE HYDROCHLORIDE |
Package Description | 5 mL in 1 BOTTLE (61314-019-05) |
Product NDC | 61314-019 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dorzolamide hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20090601 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc. |
Substance Name | DORZOLAMIDE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |